[{"NetIncomeLoss_1_Q3_USD":-14505000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":10331650.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":10441384.0,"CommitmentsAndContingencies_0_Q3_USD":null,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_3_Q3_pure":0.9,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum_1_Q3_pure":0.89,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_3_Q3_pure":0.012,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum_1_Q3_pure":0.005,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-12000.0,"Depreciation_3_Q3_USD":100000.0,"Depreciation_1_Q3_USD":34000.0,"StockIssuedDuringPeriodValueNewIssues_1_Q3_USD":1140000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":4112000.0,"AssetsCurrent_0_Q3_USD":111970000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":15350257.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q3_USD":171000.0,"IncomeTaxesPaidNet_3_Q3_USD":17000.0,"CommonStockSharesIssued_0_Q3_shares":10495732.0,"Assets_0_Q3_USD":113044000.0,"ShareBasedCompensation_3_Q3_USD":6609000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":354000.0,"CommonStockCapitalSharesReservedForFutureIssuance_0_Q3_shares":16386314.0,"DeferredRevenue_0_Q3_USD":200000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":1140000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.001,"OtherNoncashIncomeExpense_3_Q3_USD":-108000.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q3_USD":29000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":14916000.0,"OperatingLeaseLiability_0_Q3_USD":410000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":32212000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":10432000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q3_USD":439000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_3_Q3_USD":-23000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":495000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-22000.0,"IncomeTaxExpenseBenefit_3_Q3_USD":106000.0,"IncomeTaxExpenseBenefit_1_Q3_USD":39000.0,"IncreaseDecreaseInDeferredRevenue_3_Q3_USD":200000.0,"CommonStockValue_0_Q3_USD":10000.0,"OtherReceivablesNetCurrent_0_Q3_USD":328000.0,"MoneyMarketFundsAtCarryingValue_0_Q3_USD":106277000.0,"DepreciationDepletionAndAmortization_3_Q3_USD":191000.0,"FairValueAdjustmentOfWarrants_3_Q3_USD":16240000.0,"OtherAssetsCurrent_0_Q3_USD":708000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":5727000.0,"AccruedEmployeeBenefitsCurrent_0_Q3_USD":3003000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":531000.0,"OtherAssetsNoncurrent_0_Q3_USD":657000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":109014000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":217000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":933916000.0,"Cash_0_Q3_USD":2737000.0,"Liabilities_0_Q3_USD":7684000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":1140000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":586000.0,"OperatingLeaseImpairmentLoss_3_Q3_USD":106000.0,"OperatingLeaseImpairmentLoss_1_Q3_USD":100000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_3_Q3_USD":-62773000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q3_USD":-14466000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":2074000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-39619000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q3_USD":215000.0,"LiabilitiesCurrent_0_Q3_USD":7467000.0,"AccountsPayableCurrent_0_Q3_USD":1540000.0,"NonoperatingIncomeExpense_3_Q3_USD":-15745000.0,"NonoperatingIncomeExpense_1_Q3_USD":-22000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_0_Q3_USD":109314000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":2956000.0,"AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment_0_Q3_USD":505000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_3_Q3_pure":0.88,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":77000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q3_pure":0.065,"ShortTermLeaseCost_3_Q3_USD":36000.0,"ShortTermLeaseCost_1_Q3_USD":7000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_3_Q3_pure":0.003,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum_1_Q3_pure":0.003,"OperatingLeasePayments_3_Q3_USD":157000.0,"OperatingLeasePayments_1_Q3_USD":53000.0,"PrepaidInsurance_0_Q3_USD":1464000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":63000.0,"NetIncomeLoss_3_Q3_USD":-62879000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum_1_Q3_pure":0.88,"FederalIncomeTaxExpenseBenefitContinuingOperations_1_Q3_USD":0.0,"FederalIncomeTaxExpenseBenefitContinuingOperations_3_Q3_USD":0.0,"CommonStockSharesOutstanding_0_Q3_shares":10495732.0,"CommonStockSharesAuthorized_0_Q3_shares":500000000.0,"OperatingIncomeLoss_3_Q3_USD":-47028000.0,"OperatingIncomeLoss_1_Q3_USD":-14444000.0,"OperatingLeaseCost_3_Q3_USD":152000.0,"OperatingLeaseCost_1_Q3_USD":51000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":113044000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":6609000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":2074000.0,"PropertyPlantAndEquipmentGross_0_Q3_USD":568000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":193000.0,"OperatingExpenses_3_Q3_USD":47128000.0,"OperatingExpenses_1_Q3_USD":14544000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":-1624000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-6.09,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-1.39,"ProfitLoss_3_Q3_USD":-62879000.0,"StockholdersEquity_0_Q3_USD":105360000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":12000.0,"RestrictedCashAndCashEquivalents_0_Q3_USD":300000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_3_Q3_USD":100000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q3_USD":100000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-828566000.0,"LeaseCost_3_Q3_USD":188000.0,"LeaseCost_1_Q3_USD":58000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":-38514000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q3_USD":53000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":806000.0,"Ticker":"SRRA","CIK":"1290149","name":"SIERRA ONCOLOGY, INC.","OfficialName":"Sierra Oncology Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1244659116.0","Country":"Canada","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]